热门资讯> 正文
Protara Therapeutics GAAP每股收益为-0.97美元
2024-05-02 20:49
- Protara Therapeutics press release (NASDAQ:TARA): Q1 GAAP EPS of -$0.97.
- cash, cash equivalents and investments in marketable debt securities totaled $55.2 million.
-
More on Protara Therapeutics
- Protara: A Bombed Out Biotech With A Very Positive Skew
- Protara Therapeutics jumps 23% on $45M oversubscribed private financing
- Seeking Alpha’s Quant Rating on Protara Therapeutics
- Historical earnings data for Protara Therapeutics
- Financial information for Protara Therapeutics
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。